[NeurogesX Letterhead]
October 12, 2010
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Mail Stop 4720
Washington, D.C. 20549
Attention: | Jeffrey P. Riedler, Assitant Director | |
Jim B. Rosenberg, Senior Assistant Chief Accountant | ||
Sasha Parikh, Staff Accountant | ||
Mark Brunhofer, Review Accountant | ||
Michael Rosenthall | ||
Re: | NeurogesX, Inc. | |
Form 10-K for the Fiscal Year Ended December 31, 2009 | ||
Form 10-Q for the quarter ended June 30, 2010 | ||
Definitive Proxy Statement on Schedule 14A Filed April 20, 2010 | ||
File No. 001-33438 |
Dear Mr. Rosenberg:
On behalf of NeurogesX, Inc. (the “Company”), this letter is being submitted in reference to the Securities and Exchange Commission’s (the “Commission”) letter to Anthony DiTonno, President and Chief Executive Officer of the Company, dated September 27, 2010 (the “Comment Letter”).
The Company is working expeditiously to respond to the Comment Letter. However, in order to fully address the comments from the staff of the Commission (the “Staff”), the Company respectfully requests an extension of time to respond to the inquiries contained in the Comment Letter. The Company currently anticipates submitting a response to the Comment Letter on or before October 15, 2010.
Securities and Exchange Commission
October 12, 2010
Page 2
Please do not hesitate to contact me (650-358-3300), or Michael O’Donnell or Gavin McCraley at Wilson, Sonsini, Goodrich & Rosati, P.C. (650-493-9300), with any concerns you may have regarding the timetable described above. Thank you for your consideration.
Sincerely, |
NeurogesX, Inc. |
/S/ Stephen Ghiglieri |
Stephen Ghiglieri |
Executive Vice President, Chief Operating Officer and Chief Financial Officer |
cc: | Anthony DiTonno, | |
President and Chief Executive Officer | ||
NeurogesX, Inc. | ||
Michael O’Donnell, Esq. | ||
Gavin McCraley, Esq. | ||
Wilson Sonsini Goodrich & Rosati, Professional Corporation |